|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Lung Biology, University of South Alabama, Mobile, Alabama, United States
2 Cell Biology and Neuroscience, University of South Alabama, Mobile, Alabama, United States
3 Departments of Pharmacology and Pathology, University of South Alabama, Mobile, Alabama, United States
4 Pediatrics, University of Indiana, Indianapolis, Indiana, United States
5 Department of Pharmacology, University of South Alabama College of Medicine, Mobile, Alabama, United States
* To whom correspondence should be addressed. E-mail: tstevens{at}jaguar1.usouthal.edu.
Pulmonary microvascular endothelial cells (PMVECs) are enriched with progenitor cells that underlie their rapid proliferation and vasculogenic capacity. However, the molecular basis for such an enhanced growth potential is unknown. Nucleosome assembly protein-1 (NAP1), and its related family of proteins, has been incriminated in control of cell growth in a range of species. We therefore sought to determine whether NAP1 contributes to the rapid proliferation and vasculogenesis that is observed in PMVECs. NAP1 was expressed at a high level in two fast growing cell types, including PMVECs and resident microvascular endothelial progenitor cells that were selected from PMVECs, whereas it was expressed at a low level in slow growing pulmonary artery endothelial cells (PAECs). Heterologous NAP1 expression increased the growth potential of PAECs, whereas inhibiting NAP1 expression reduced the growth potential of PMVECs. To examine whether the growth promoting actions of NAP1 influence blood vessel formation, endothelial cells were mixed into Matrigel and subcutaneously implanted. PMVECs generated 8-fold more blood vessels than did PAECs over a 10-day time course. Heterologous NAP1 expression in PAECs increased the number of blood vessels formed by this cell type, where blood vessel growth approached that seen with PMVECs. Thus, our findings indicate that NAP1 functions as an important regulator of the proliferative and vasculogenic endothelial cell phenotype, without globally impacting endothelial cell phenotype specification.
This article has been cited by other articles:
![]() |
D. F. Meoli and R. J. White Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium/calmodulin-dependent protein kinase II Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L706 - L714. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhu, L. Zhang, M. Alexeyev, D. F. Alvarez, S. J. Strada, and T. Stevens Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L220 - L228. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stevens, S. Phan, M. G. Frid, D. Alvarez, E. Herzog, and K. R. Stenmark Lung Vascular Cell Heterogeneity: Endothelium, Smooth Muscle, and Fibroblasts Proceedings of the ATS, September 15, 2008; 5(7): 783 - 791. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |